lymphokine-activated killer cells
Term · Oncology and biomedicine · MLC-T-ONC-014947
Killer cell lymphocytes activated in the presence of interleukin-2 (IL-2). Lymphokine-activated killer cells (LAKs) are cytotoxic effector cells with an exceptionally wide target cell spectrum including normal and malignant cells of different origins. LAK cells exhibit a profound heterogeneity with regard to phenotype surface marker expression; it remains to be determined if they represent a unique cell lineage.
| Identifier | MLC-T-ONC-014947 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | LAK |
| Synonyms | therapeutic lymphokine-activated killer cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014947",
"term": "lymphokine-activated killer cells",
"field": "Oncology and biomedicine",
"definition": "Killer cell lymphocytes activated in the presence of interleukin-2 (IL-2). Lymphokine-activated killer cells (LAKs) are cytotoxic effector cells with an exceptionally wide target cell spectrum including normal and malignant cells of different origins. LAK cells exhibit a profound heterogeneity with regard to phenotype surface marker expression; it remains to be determined if they represent a unique cell lineage.",
"abbreviation": "LAK",
"synonyms": [
"therapeutic lymphokine-activated killer cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/lymphokine-activated-killer-cells/"
}
Record 10,480 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.